guaifenesin has been researched along with Genetic Predisposition in 15 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The term phenotype in the field of COPD is defined as "a single or combination of disease attributes that describe differences between individuals with COPD as they relate to clinically meaningful outcomes"." | 2.48 | Clinical phenotypes of COPD: identification, definition and implications for guidelines. ( Calle, M; Miravitlles, M; Soler-Cataluña, JJ, 2012) |
| "Diffuse panbronchiolitis is characterized by chronic inflammation in respiratory bronchioles and sinobronchial infection." | 2.47 | Genetic predisposition to diffuse panbronchiolitis. ( Hijikata, M; Keicho, N, 2011) |
| "The development of COPD is associated with chronic pulmonary inflammation." | 2.46 | [COPD and inflammation: statement from a French expert group: inflammation and remodelling mechanisms]. ( Aguilaniu, B; Aubier, M; Berger, P; Brillet, PY; Burgel, PR; Chambellan, A; Chanez, P; Chaouat, A; Devillier, P; Escamilla, R; Louis, R; Mal, H; Marthan, R; Muir, JF; Pérez, T; Roche, N; Similowski, T; Wallaert, B, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, W | 1 |
| Moninger, TO | 1 |
| Thurman, AL | 1 |
| Xie, Y | 1 |
| Jain, A | 1 |
| Zarei, K | 1 |
| Powers, LS | 1 |
| Pezzulo, AA | 1 |
| Stoltz, DA | 1 |
| Welsh, MJ | 1 |
| Packer, RJ | 1 |
| Shrine, N | 1 |
| Hall, R | 1 |
| Melbourne, CA | 1 |
| Thompson, R | 1 |
| Williams, AT | 1 |
| Paynton, ML | 1 |
| Guyatt, AL | 1 |
| Allen, RJ | 1 |
| Lee, PH | 1 |
| John, C | 1 |
| Campbell, A | 1 |
| Hayward, C | 1 |
| de Vries, M | 1 |
| Vonk, JM | 1 |
| Davitte, J | 1 |
| Hessel, E | 1 |
| Michalovich, D | 1 |
| Betts, JC | 1 |
| Sayers, I | 1 |
| Yeo, A | 1 |
| Hall, IP | 1 |
| Tobin, MD | 1 |
| Wain, LV | 1 |
| Al-Shaibi, AA | 1 |
| Abdel-Motal, UM | 1 |
| Hubrack, SZ | 1 |
| Bullock, AN | 1 |
| Al-Marri, AA | 1 |
| Agrebi, N | 1 |
| Al-Subaiey, AA | 1 |
| Ibrahim, NA | 1 |
| Charles, AK | 1 |
| Elawad, M | 1 |
| Uhlig, HH | 1 |
| Lo, B | 1 |
| Mizoguchi, A | 1 |
| Yano, A | 1 |
| Himuro, H | 1 |
| Ezaki, Y | 1 |
| Sadanaga, T | 1 |
| Mizoguchi, E | 1 |
| Schwartz, DA | 1 |
| Gao, N | 1 |
| Bergstrom, K | 1 |
| Fu, J | 1 |
| Xie, B | 1 |
| Chen, W | 1 |
| Xia, L | 1 |
| Taylor-Cousar, JL | 1 |
| Zariwala, MA | 1 |
| Burch, LH | 1 |
| Pace, RG | 1 |
| Drumm, ML | 1 |
| Calloway, H | 1 |
| Fan, H | 1 |
| Weston, BW | 1 |
| Wright, FA | 1 |
| Knowles, MR | 1 |
| Park, SW | 1 |
| Zhen, G | 1 |
| Verhaeghe, C | 1 |
| Nakagami, Y | 1 |
| Nguyenvu, LT | 1 |
| Barczak, AJ | 1 |
| Killeen, N | 1 |
| Erle, DJ | 1 |
| Aubier, M | 1 |
| Marthan, R | 1 |
| Berger, P | 1 |
| Chambellan, A | 1 |
| Chanez, P | 1 |
| Aguilaniu, B | 1 |
| Brillet, PY | 1 |
| Burgel, PR | 1 |
| Chaouat, A | 1 |
| Devillier, P | 1 |
| Escamilla, R | 1 |
| Louis, R | 1 |
| Mal, H | 1 |
| Muir, JF | 1 |
| Pérez, T | 1 |
| Similowski, T | 1 |
| Wallaert, B | 1 |
| Roche, N | 1 |
| Keicho, N | 1 |
| Hijikata, M | 1 |
| Miravitlles, M | 1 |
| Calle, M | 1 |
| Soler-Cataluña, JJ | 1 |
| Anagnostopoulou, P | 1 |
| Riederer, B | 1 |
| Duerr, J | 1 |
| Michel, S | 1 |
| Binia, A | 1 |
| Agrawal, R | 1 |
| Liu, X | 1 |
| Kalitzki, K | 1 |
| Xiao, F | 1 |
| Chen, M | 1 |
| Schatterny, J | 1 |
| Hartmann, D | 1 |
| Thum, T | 1 |
| Kabesch, M | 1 |
| Soleimani, M | 1 |
| Seidler, U | 1 |
| Mall, MA | 1 |
| Matejusová, I | 1 |
| Felix, B | 1 |
| Sorsa-Leslie, T | 1 |
| Gilbey, J | 1 |
| Noble, LR | 1 |
| Jones, CS | 1 |
| Cunningham, CO | 1 |
| Leikauf, GD | 1 |
| Borchers, MT | 1 |
| Prows, DR | 1 |
| Simpson, LG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Gene Modifiers of Cystic Fibrosis Lung Disease[NCT00037765] | 600 participants (Anticipated) | Observational | 2001-09-30 | Active, not recruiting | |||
| Efficacy and Safety of Fluticasone Furoate/Vilanterol vs. Umeclidinium/Vilanterol in Patients With COPD-asthma Phenotype vs. Emphysema Phenotype. A Controled Clinical Trial.[NCT05342558] | Phase 4 | 133 participants (Actual) | Interventional | 2017-09-19 | Completed | ||
| Raman Analysis of Saliva From COPD Patients as New Biomarker: AI-based Point-of-care for the Disease Monitoring and Management[NCT04628962] | 250 participants (Anticipated) | Observational | 2022-02-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for guaifenesin and Genetic Predisposition
| Article | Year |
|---|---|
Clinical importance of IL-22 cascade in IBD.
Topics: Gastrointestinal Agents; Genetic Predisposition to Disease; Humans; Immunity, Mucosal; Inflammatory | 2018 |
Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways.
Topics: Genetic Predisposition to Disease; Humans; Idiopathic Pulmonary Fibrosis; Mucin-5B; Mucus; Promoter | 2018 |
[COPD and inflammation: statement from a French expert group: inflammation and remodelling mechanisms].
Topics: Airway Remodeling; Anemia; Antigens; Antioxidants; Bronchitis; Cardiovascular Diseases; Comorbidity; | 2010 |
Genetic predisposition to diffuse panbronchiolitis.
Topics: Asia, Eastern; Bronchiolitis; Chromosomes, Human, Pair 6; Cystic Fibrosis; Female; Foam Cells; Genet | 2011 |
Clinical phenotypes of COPD: identification, definition and implications for guidelines.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Asthma; Bronchiectasis; Bronchitis; Bronchodilato | 2012 |
Clinical phenotypes of COPD: identification, definition and implications for guidelines.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Asthma; Bronchiectasis; Bronchitis; Bronchodilato | 2012 |
Clinical phenotypes of COPD: identification, definition and implications for guidelines.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Asthma; Bronchiectasis; Bronchitis; Bronchodilato | 2012 |
Clinical phenotypes of COPD: identification, definition and implications for guidelines.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Asthma; Bronchiectasis; Bronchitis; Bronchodilato | 2012 |
Mucin apoprotein expression in COPD.
Topics: Acrolein; Animals; Gene Expression Regulation; Genetic Predisposition to Disease; Humans; Mice; Muci | 2002 |
9 other studies available for guaifenesin and Genetic Predisposition
| Article | Year |
|---|---|
Cellular and molecular architecture of submucosal glands in wild-type and cystic fibrosis pigs.
Topics: Acinar Cells; Animals; Biomarkers; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regula | 2022 |
Genome-wide association study of chronic sputum production implicates loci involved in mucus production and infection.
Topics: Genetic Predisposition to Disease; Genome-Wide Association Study; HLA-DRB1 Chains; Humans; Mucins; M | 2023 |
Human AGR2 Deficiency Causes Mucus Barrier Dysfunction and Infantile Inflammatory Bowel Disease.
Topics: Amino Acid Sequence; Animals; Biomarkers; Disease Models, Animal; Disease Susceptibility; Endoplasmi | 2021 |
Loss of intestinal O-glycans promotes spontaneous duodenal tumors.
Topics: Adenocarcinoma; Animals; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Duodenal Ne | 2016 |
Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity.
Topics: ABO Blood-Group System; Adolescent; Adult; Blood Group Antigens; Cystic Fibrosis; Female; Genetic Pr | 2009 |
The protein disulfide isomerase AGR2 is essential for production of intestinal mucus.
Topics: Acute Disease; Animals; Cell Lineage; Colitis; Disulfides; Endoplasmic Reticulum; Epithelial Cells; | 2009 |
[Chronic lung disease -- genetics for bronchial hypersecretion discovered].
Topics: Bronchi; Genetic Predisposition to Disease; Humans; Lung Injury; Mucus | 2009 |
SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation.
Topics: 3' Untranslated Regions; Airway Obstruction; Animals; Antiporters; Asthma; Bronchitis; Calcium; Chil | 2012 |
Gene expression profiles of some immune relevant genes from skin of susceptible and responding Atlantic salmon (Salmo salar L.) infected with Gyrodactylus salaris (Monogenea) revealed by suppressive subtractive hybridisation.
Topics: Animals; Base Sequence; Ectoparasitic Infestations; Fish Diseases; Gene Expression Profiling; Geneti | 2006 |